Pedro Ochoa-Allemant is a Clinical Fellow in Advanced/Transplant Hepatology at the University of Pennsylvania. Born and raised in Lima, Peru, Dr. Ochoa-Allemant earned his medical degree from the Universidad de San Martin de Porres. He completed a two-year postdoctoral research fellowship at Harvard Medical School, followed by an Internal Medicine residency at Yale School of Medicine, where he graduated with an Investigation Distinction.

GI Fellow, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia

First-year gastroenterology fellow at UCLA with plans to pursue advanced training in hepatology and transplant hepatology. She aspires to build a career as a clinician-researcher, with a focus on health services research aimed at addressing health inequities among patients with decompensated cirrhosis. Her research interests in health services research includes work grounded in amplifying patient perspectives to inform more equitable and patient-centered models of care.

Gastroenterology & Hepatology Fellow, Stanford University School of Medicine

I am a transplant hepatologist at the University of North Carolina in Chapel Hill. I have a special interest in alcohol-related liver disease, and I am the Director of UNC's Integrated Healthcare for Alcohol Use and Liver Disease (IHEAL) Clinic. I am active in AASLD through my work as a co-founder of Liver Fellow Network and currently as a Chair-Elect of AASLD's Practice Metrics Committee.

Dr. Lizaola-Mayo is an Associate Professor of Medicine at the Division of Gastroenterology and Hepatology at Mayo Clinic College of Medicine. She is a Transplant Hepatologist and is the Medical Director of the Transplant Hepatology Center at Mayo Clinic in Arizona. Dr. Lizaola-Mayo is interested and has focused her research on metabolic dysfunction-associated steatotic liver disease (MASLD), health disparities and post-transplant outcomes.

Dr. Rebecca Kim is a transplant hepatologist and health services researcher at University of Utah Health. Her research focuses on understanding the impact of social drivers of health (SDoH) on disparities in patients with chronic liver disease (CLD), specifically metabolic dysfunction-associated steatotic liver disease, and how the intervention of modifiable SDoH can improve care for patients with CLD among vulnerable populations. Dr. Kim is a member of University of Utah Health's SDoH Screening Committee and the Health Equity Research Section and Workgroup.

Dr. Daniela Goyes is a Gastroenterology Fellow at Yale University and an incoming Liver Transplant Fellow. Her research and clinical interests center on portal hypertension and autoimmune liver diseases.

Transplant hepatology fellow at the University of Michigan and co-lead of the Liver Fellow Network